Entyvio 300 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FDJE8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,523
Award facts
- Contract value 100% obligated
- $19,522.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,522.72 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The award was issued on December 3, 2025, with an ultimate completion date of December 4, 2025, and carries no set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy established to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial capability as a critical supplier within the federal pharmaceutical supply chain, having been registered in the System for Award Management since 2001 and maintaining consistent contract performance across multiple therapeutic categories. The company's established prime vendor contract extends through December 31, 2036, with a ceiling value of $499,999,999 and includes three 30-month option periods. Through the PPV-G GEN V vehicle, the company is authorized to supply a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, vaccines, and medical consumables to support military healthcare operations globally. No subcontractors have been identified in the award documentation for this delivery order.
Quick answers
Who was awarded contract SPE2DR26FDJE8?
SPE2DR26FDJE8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FDJE8 worth?
The government has obligated $19,523 on SPE2DR26FDJE8.
Is contract SPE2DR26FDJE8 an order under another contract?
Yes. SPE2DR26FDJE8 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJE8 competed?
The extent of competition for SPE2DR26FDJE8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award